Sarepta Therapeutics, a leading biopharmaceutical company, is dedicated to developing innovative therapies for neuromuscular diseases. They specialize in areas such as Duchenne Muscular Dystrophy, Limb-girdle Muscular Dystrophy, and Charcot-Marie-Tooth Disease. At Sarepta, their cutting-edge science revolves around various platforms, including Gene Therapy Engine, RNA Platform, Gene Editing, and Manufacturing.

They also prioritize strategic partnerships to further enhance their research and development efforts. With a strong commitment to patient care, Sarepta offers a range of FDA-approved therapies for Duchenne through their SareptAssist Patient Support program. This program assists patients and families with therapy continuation, insurance, and reimbursement matters.

Additionally, they provide medical information for healthcare providers and welcome general inquiries about their therapies in development. For investors, media, and business development opportunities, Sarepta offers dedicated contact points. They also value their employees and provide human resources support.

To get in touch with Sarepta, simply fill out their contact form or utilize the provided phone numbers and email addresses. Sarepta Therapeutics, dedicated to improving lives through innovative therapies